LAG3 and in situ carcinoma: In addition to PD1, Lag3 and Tigit have also become increasingly important immune checkpoint molecules in T‐cell exhaustion.[26] We also observed high Lag3 and Tigit expression in the CD8+ T cells of both CIS and SCC (Figure 5G).